LYRA (Lyra Therapeutics, Inc.) Earnings per share growth rate in current year

Corporate emblem and logo of Lyra Therapeutics, Inc. (LYRA)

The annual EPS change step clearly demonstrates the consequences of the Phase 3 trial collapse, which led to restructuring and a loss of market position for Lyra Therapeutics, Inc. (LYRA). Previously, the business relied on creating unique implants for ENT pathologies with high margin potential. Revenues were planned through the supply of sinusitis treatment systems to clinics. The current value of 0.00 expresses the metric level, helping to identify a trend reversal in a timely manner.

LYRA (Lyra Therapeutics Inc.) Earnings per share growth in current year history from 07/04/2022 to 03/28/2026

Analytical breakdowns and data insights for company Lyra Therapeutics (LYRA)

Fundamental valuation:Lyra Therapeutics, Inc.
Signature product of lyratherapeutics.com

During periods of volatility, investors seek instruments to protect capital from systemic risks. The unique implantable systems of Lyra Therapeutics, Inc. (LYRA) and its patent protection establish a foundation for future margins. The annual growth rate of net income per share measures profitability dynamics by comparing the current EPS with the previous year. This chart allows for an assessment of the business's adaptability to external shocks. A positive trajectory confirms the resilience of the model and the potential for free cash flow growth.

Key competitors

Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|Expected net earnings per share growth this year liquidia.com LQDA|Galapagos (GLPG) - Earnings per share growth in current year|ANIP - Expected net earnings per share growth this year|Earnings per share growth in current year MannKind Corporation|AMPH: Earnings per share increase in current year|Earnings per share growth in current year Pacira BioSciences (PCRX)|SPRY: Earnings per share trend in current year|Theravance Biopharma, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year AQST (Aquestive Therapeutics, Inc.)|SCPH - Earnings per share growth in current year|Expected net earnings per share growth this year tectonictx.com TECX|TNXP: Earnings growth in current year|Earnings per share growth this year SXTC|Net earnings per share growth this year EPRX|BioHarvest (BHST) - Expected net earnings per share growth this year|Earnings growth in current year EXOZ|Earnings growth in current year Oramed (ORMP)|Entera Bio Ltd. - Net earnings per share growth this year|ipatherapeutics.com (HYFT) - Earnings per share growth rate in current year|ABVC - Earnings per share growth in current year|Earnings per share trend in current year CPIX|QNTM: Earnings growth in current year|FGEN - Expected net earnings per share growth this year|TELO (Telomir Pharmaceuticals Corp) - Earnings growth in current year|RANI (Rani Therapeutics) - Net earnings per one share growth for the current year|Earnings per share growth in current year Synergy CHC Corp. (SNYR)|RLYB (Rallybio) - Earnings per share increase in current year|Earnings per share growth in current year lexariabioscience.com LEXX|Earnings growth in current year Pulmatrix Corporation PULM|PTHL - Earnings per share growth in current year|Expected net earnings per share growth this year Aptorum Group Ltd APM|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals